Ignite Creation Date:
2025-12-26 @ 11:12 AM
Ignite Modification Date:
2026-01-01 @ 12:59 AM
Study NCT ID:
NCT03288428
Status:
UNKNOWN
Last Update Posted:
2017-11-06
First Post:
2017-06-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Analgesia Comparison of Nalbuphine and Morphine for Laparoscopic Myomectomy
Sponsor:
Peking University First Hospital
Organization:
Study Overview
Official Title:
Analgesia Comparison of Nalbuphine and Morphine for Laparoscopic Myomectomy
Status:
UNKNOWN
Status Verified Date:
2017-11
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
to compare the analgesia and side effect of nalbuphine and morphine for elective Laparoscopic myomectomy.
Detailed Description:
To compare the analgesia and side effect of nalbuphine and morphine for elective Laparoscopic myomectomy, by using patient controlled analgesia postoperatively, a randomized, double blind clinical trial. Patients undergoing elective Laparoscopic myomectomy are randomly divided into two groups: nalbuphine and morphine groups. All patients are under general anesthesia with routine methods. The nalbuphine group receive postoperative patient controlled analgesia using nalbuphine 30mg/120ml, while the morphine group receive postoperative patient controlled analgesia using morphine 60mg/120ml. Perioperative parameters are to be collected to compare the two groups.
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: